News | Ultrasound Imaging | June 04, 2018

Olympus and Hitachi Healthcare Americas Introduce Arietta 850

Partnership with Hitachi Ltd. ushers in next-evolution ultrasound processor; provides endoscopists with a greater depth of information

Olympus and Hitachi Healthcare Americas Introduce Arietta 850

Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, and Hitachi Healthcare Americas, a leading company in Ultrasound and CT/MRI medical imaging, announced today an agreement in the U.S. to distribute the ARIETTA 850, a premium ultrasound processor that provides endoscopists with a greater depth of information toward improved decision making, with backing by industry-leading service and support. The ARIETTA 850, the latest introduction from a continued partnership with Hitachi Healthcare Americas, features a new OLED monitor and eFocusing technology that enhance the ultrasound image, allowing for more detailed observation. It also provides an extensive variety of imaging modalities such as Real-time Tissue Elastography and Strain Histogram Measurement, enabling a comprehensive examination.  "The ARIETTA 850 premium ultrasound system expands clinical utility by offering the most advanced applications, such as elastography for GI tract diseases," said John Waddell, senior vice president of sales and marketing for Hitachi Healthcare Americas. "Through our partnership with Olympus, these capabilities can support multidisciplinary diagnosis and treatment to achieve better outcomes."

Endoscopic ultrasound (EUS) combines ultrasound technology with endoscopy to gain an internal vantage point for better visualization. While conventional endoscopy only provides a view of the innermost lining of the digestive tract, or its wall, the addition of ultrasound allows the physician to see beyond that wall to visualize all five layers of the GI tract as well as surrounding tissue and organs.  EUS also provides a minimally invasive means for biopsy.

Olympus and Hitachi have successfully continued a long standing strategic alliance in endoscopic ultrasound and due to this continued partnership, the Olympus market leading ultrasound endoscopes continue to be compatible with Hitachi's sophisticated ultrasound technology. Through this new introduction, the ARIETTA 850 provides U.S. customers:

  • Clinical Value: A new OLED monitor and eFocusing technology enhance the ultrasound image, allowing for more detailed observation.
  • Economic Value: Forward/backward compatibility provides lower cost of ownership and more efficient use of assets while on-site support from clinical application specialists reduces training costs.
  • Efficiency: Real-time Tissue Elastography and Strain Histogram Measurement enable a comprehensive examination.

"Our endoscopic capabilities are much expanded with the benefit of ultrasound, to diagnose and treat a range of conditions," said Dr. David Diehl, Geisinger Health System. "We are excited that Olympus has once again partnered with Hitachi to bring us exciting advancements in image quality and technology."

"Robust partnerships and understanding our customer needs contribute to Olympus standing at the forefront of the exciting and growing endoscopic ultrasound field," said Kurt Heine, group vice president of the endoscopy division at Olympus America Inc. "The ARIETTA 850 is the next iteration of our commitment to stay true to quality medical device innovation that drives optimal clinical outcomes, provides a lower total cost of ownership, and enhances patient satisfaction."

For more information: http://medical.olympusamerica.com/articles/olympus-and-hitachi-healthcar...

Related Content

#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Getty Images

Feature | Coronavirus (COVID-19) | April 03, 2020 | By Melinda Taschetta-Millane and Dave Fornell
In an effort to keep the imaging field updated on the latest information being released on coronavirus (COVID-19), th
An estimated 44 million people worldwide are currently living with Alzheimer’s disease, the most common form of dementia. About 5.8 million people in the United States live with the disease, where it is the sixth leading cause of death overall. While there is not yet a cure for Alzheimer’s, researchers are working to find treatment options to delay its onset and prevent it from developing.

Image courtesy of Insightec

Feature | Ultrasound Imaging | April 02, 2020 | By Katie Caron
An estimated 44 million people worldwide are currently living with...
An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal.

An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal. Photo by Dave Fornell

Feature | Radiology Imaging | April 02, 2020 | By Katie Caron
A new year — and decade — offers the opportunity to reflect on the advancements and challenges of years gone by and p
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Esaote won a tender launched by Consip on behalf of Civil Protection for the distribution of diagnostic equipment in Italy to face COVID-19 emergency.

Esaote won a tender launched by Consip on behalf of Civil Protection for the distribution of diagnostic equipment in Italy to face COVID-19 emergency.

News | Ultrasound Imaging | April 02, 2020
April 2, 2020 — Esaote, an Italian company among the world leader
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 A brief article from Henry Ford Health System in Detroit, published today in Radiology, reports on the first presumptive case of COVID-19–associated acute necrotizing hemorrhagic encephalopathy.

A, Image from noncontrast head CT demonstrates symmetric hypoattenuation within the bilateral medial thalami (arrows). B, Axial CT venogram demonstrates patency of the cerebral venous vasculature, including the internal cerebral veins (arrows). C, Coronal reformat of aCT angiogram demonstrates normal appearance of the basilar artery and proximal posterior cerebral arteries. Image courtesy of the Radiological Society of North America (RSNA)

News | Coronavirus (COVID-19) | March 31, 2020
March 31, 2020 — A brief article fr
RSNA's open data repository will compile images and correlative data to create a comprehensive source for COVID-19 research and education efforts #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
News | Coronavirus (COVID-19) | March 30, 2020
March 30, 2020 — The medical imaging community around the world is uniting to help address the...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Typical CT imaging features for COVID-19. Unenhanced, thin-section axial images of the lungs in a 52-year-old man with a positive RT-PCR (A-D) show bilateral, multifocal rounded (asterisks) and peripheral GGO (arrows) with superimposed interlobular septal thickening and visible intralobular lines (“crazy-paving”). Routine screening CT for diagnosis or exclusion of COVID-19 is currently not recommended by most professional organizations or the US Centers for Disease Control and Prevention. Image courtesy of RSNA

News | Coronavirus (COVID-19) | March 26, 2020
March 26, 2020 — The Radiological Society of North America (RSNA
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Representative examples of the attention heatmaps generated using Grad-CAM method for (a) COVID-19, (b) CAP, and (c) Non-Pneumonia. The heatmaps are standard Jet colormap and overlapped on the original image, the red color highlights the activation region associated with the predicted class. COVID-19 = coronavirus disease 2019, CAP = community acquired pneumonia. Image courtesy of the journal Radiology

News | Coronavirus (COVID-19) | March 20, 2020
March 20, 2020 — An arti...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Series CT scans in 35-year-old woman with COVID-19 pneumonia. (a) Scan obtained on illness days 1 showed multiple pure ground-glass opacity (GGO) mainly in right lower lobe. (b) Scan obtained on illness days 5 showed increased extent of GGO and early consolidation. (c) Scan obtained on illness days 11 showed multiple consolidation with almost the same extent. (d) Scan obtained on illness days 15 showed a mixed pattern with a slightly smaller extent, and the perilobular consolidation might suggest the presence of organizing pneumonia. The patient was discharged on illness days 17. Image courtesy of the journal Radiology

News | Coronavirus (COVID-19) | March 20, 2020
March 20, 2020 — In a new study pub